Table 1: Case profiles *: disease (cases): prostate cancer(2), breast cancer(1), renal cancer(1), uterus cancer(1), bladder cancer(1), plastic surgery(1), dyalysis shunt(1), **: SU (mg per day) : glimepirid 1.3±1.1, glibencramid 5.6±3.1. ***: insulin dose (unit per day) 10.6±5.0.
| Total |
Number of cases(male/female) | 73(40/33) |
Number of procedures(male/female) | 86(49/37) |
Age(yrs) | 69.5±11.0 |
NbA1c(%) | 7.8±1.3 |
MBI | 26.6±4.1 |
Disease durations(yrs) | 11.7±10.7 |
| Orthopedics operations | Cardiac catheterization | Ophthalmological operations | Others | | |
Number of cases(male/female) | 40(17/23) | 12(10/2) | 13(9/4) | 8(4/4) | | |
Number of procedures(male/female) | 43(18/25) | 19(17/2) | 18(12/6) | 9(5/4) | | |
Age | 67.8±13.5 | 68.4±7.9 | 72.7±7.4 | 74.9±3.2 | | |
BMI | 27.2±4.0 | 24.0±2.4 | 24.4±2.8 | 29.0±7.6 | | |
HbA1c(%) | 7.4±1.1 | 8.6±1.8 | 8.6±1.1 | 7.6±0.5 | | |
Disease duration(yrs) | 11.2±10.7 | 14.0±12.6 | Unknown | 9.5±7.8 | | |
Medications administered before Lira therapy |
None | | 8 | 4 | 1 | 1 | 1 |
OAD | Number of medications | 1 | 5 | 0 | 1 | 1 |
| | 2 | 15 | 2 | 5 | 3 |
| | 3 | 3 | 2 | 0 | 0 |
| | 4 | 5 | 1 | 0 | 0 |
| | With SU** | 17 | 4 | 2 | 4 |
Insulin therapy*** | 4 | 3 | 6 | 3 | | |
Fasting CPI | 1.4±0.6 | 1.3±0.1 | NM | NM | | |
uCPR(μ/day) | 94.0±60.6 | 77.7 | NM | NM | | |